189 related articles for article (PubMed ID: 11272120)
1. Studies on the mechanism by which a tumor promoter inhibits binding of epidermal growth factor to cellular receptors.
Lee LS; Weinstein IB
Carcinogenesis; 1980 Aug; 1(8):669-79. PubMed ID: 11272120
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of epidermal growth factor binding to cultured mouse epidermal cells by tumor promoters.
Murray AW; Froscio M
Carcinogenesis; 1980 Aug; 1(8):681-4. PubMed ID: 11272121
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of tumor promoter inhibition of cellular binding of epidermal growth factor.
Lee LS; Weinstein IB
Proc Natl Acad Sci U S A; 1979 Oct; 76(10):5168-72. PubMed ID: 315558
[TBL] [Abstract][Full Text] [Related]
4. Differential mechanism for the inhibition of epidermal growth factor binding to its receptor on mouse keratinocytes by anthrones and phorbol esters.
Imamoto A; Beltrán LM; DiGiovanni J
Carcinogenesis; 1990 Sep; 11(9):1543-9. PubMed ID: 2401043
[TBL] [Abstract][Full Text] [Related]
5. Transmodulation of epidermal growth factor binding by platelet-derived growth factor and 12-O-tetradecanoylphorbol-13-acetate is not sodium-dependent in Balb/c/3T3 cells.
Olson JE; Pledger WJ
J Biol Chem; 1990 Feb; 265(4):1847-51. PubMed ID: 2298725
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of the epidermal growth factor receptor at threonine 654 inhibits ligand-induced internalization and down-regulation.
Lund KA; Lazar CS; Chen WS; Walsh BJ; Welsh JB; Herbst JJ; Walton GM; Rosenfeld MG; Gill GN; Wiley HS
J Biol Chem; 1990 Nov; 265(33):20517-23. PubMed ID: 2173710
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor receptor synthesis is stimulated by phorbol ester and epidermal growth factor. Evidence for a common mechanism.
Bjorge JD; Kudlow JE
J Biol Chem; 1987 May; 262(14):6615-22. PubMed ID: 3494731
[TBL] [Abstract][Full Text] [Related]
8. Evidence for autocrine/paracrine growth stimulation by transforming growth factor-alpha during the process of skin tumor promotion.
Imamoto A; Beltrán LM; DiGiovanni J
Mol Carcinog; 1991; 4(1):52-60. PubMed ID: 2009135
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of phorbol ester on epidermal growth factor receptors in estrogen receptor-positive and -negative breast cancer cell lines.
Koga M; Musgrove EA; Sutherland RL
Cancer Res; 1990 Aug; 50(16):4849-55. PubMed ID: 2379149
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor and potent phorbol tumor promoters induce epidermal growth factor receptor phosphorylation in a similar but distinctively different manner in human epidermoid carcinoma A431 cells.
Iwashita S; Fox CF
J Biol Chem; 1984 Feb; 259(4):2559-67. PubMed ID: 6321474
[TBL] [Abstract][Full Text] [Related]
11. Phorbol diester and epidermal growth factor receptors in 12-O-tetradecanoylphorbol-13-acetate-resistant and -sensitive mouse epidermal cells.
Colburn NH; Gindhart TD; Hegamyer GA; Blumberg PM; Delclos KB; Magun BE; Lockyer J
Cancer Res; 1982 Aug; 42(8):3093-7. PubMed ID: 6284358
[TBL] [Abstract][Full Text] [Related]
12. Tumor promoter-induced inhibition of epidermal growth factor binding to cultured mouse primary epidermal cells.
Lockyer JM; Bowden GT; Matrisian LM; Magun BE
Cancer Res; 1981 Jun; 41(6):2308-14. PubMed ID: 6972249
[TBL] [Abstract][Full Text] [Related]
13. Antagonism between epidermal growth factor and phorbol ester tumor promoters in human breast cancer cells.
Osborne CK; Hamilton B; Nover M; Ziegler J
J Clin Invest; 1981 Apr; 67(4):943-51. PubMed ID: 6259217
[TBL] [Abstract][Full Text] [Related]
14. Modulation of type-IV procollagen and laminin production in A431 human squamous epidermoid carcinoma cells by 12-O-tetradecanoylphorbol-13-acetate (TPA) and epidermal growth factor (EGF).
Panneerselvam M; Sahai A; Salomon DS
Arch Dermatol Res; 1985; 277(5):377-83. PubMed ID: 3875320
[TBL] [Abstract][Full Text] [Related]
15. Amiloride inhibits constitutive internalization and increases the surface number of epidermal growth factor receptors in intact rat hepatocytes.
Gladhaug IP; Christoffersen T
J Cell Physiol; 1990 Apr; 143(1):188-95. PubMed ID: 2318906
[TBL] [Abstract][Full Text] [Related]
16. Release of a phorbol ester-induced mitogenic block by mutation at Thr-654 of the epidermal growth factor receptor.
Livneh E; Dull TJ; Berent E; Prywes R; Ullrich A; Schlessinger J
Mol Cell Biol; 1988 Jun; 8(6):2302-8. PubMed ID: 3136317
[TBL] [Abstract][Full Text] [Related]
17. Effects of epidermal growth factor and 12-O-tetradecanoylphorbol-13-acetate on metabolism of the epidermal growth factor receptor in normal human fibroblasts.
Decker SJ
Mol Cell Biol; 1984 Sep; 4(9):1718-24. PubMed ID: 6208480
[TBL] [Abstract][Full Text] [Related]
18. Differential inhibition of epidermal growth factor binding by photoactivated psoralens and the tumor promoter 12-O-tetradecanoyl phorbol-13-acetate in cells overexpressing protein kinase C.
Georgiadis C; Laskin JD
Biochem Pharmacol; 1991 Oct; 42(10):2003-9. PubMed ID: 1741777
[TBL] [Abstract][Full Text] [Related]
19. Effect of retinoic acid and 12-O-tetradecanoyl phorbol-13-acetate on the binding of epidermal growth factor to its cellular receptors.
Saito M; Ueno I; Egawa K
Biochim Biophys Acta; 1982 Aug; 717(2):301-4. PubMed ID: 6288114
[TBL] [Abstract][Full Text] [Related]
20. Phenobarbital decreases hepatocyte EGF receptor expression independent of protein kinase C activation.
Meyer SA; Jirtle RL
Biochem Biophys Res Commun; 1989 Feb; 158(3):652-9. PubMed ID: 2784053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
